The AspiriN To Inhibit SEPSIS (ANTISEPSIS) trial; an ASPREE substudy to measure the benefit of low dose aspirin in the prevention of severe sepsis.

  • Eisen, Damon P. (Primary Chief Investigator (PCI))
  • Leder, Karin (Chief Investigator (CI))
  • Mcbryde, Emma S. (Chief Investigator (CI))
  • Pilcher, David (Chief Investigator (CI))
  • Wolfe, Rory (Chief Investigator (CI))
  • Woods, Robyn (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1331/12/18

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$391,879.55